A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland

por Mononen, N, Ikonen, T, Syrjäkoski, K, Matikainen, M, Schleutker, J, Tammela, T L J, Koivisto, P A, Kallioniemi, O P
Publicado 2001

Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites

por Rapakko, K, Allinen, M, Syrjäkoski, K, Vahteristo, P, Huusko, P, Vähäkangas, K, Eerola, H, Kainu, T, Kallioniemi, O-P, Nevanlinna, H, Winqvist, R
Publicado 2001

Germline TP53 mutations in Finnish breast cancer patients

por Rapakko, K, Allinen, M, Syrjäkoski, K, Vahteristo, P, Huusko, P, Vähäkangas, K, Eerola, H, Kainu, T, Kallioniemi, O-P, Nevanlinna, H, Winqvist, R
Publicado 2000

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

por Antoniou, A C, Cunningham, A P, Peto, J, Evans, D G, Lalloo, F, Narod, S A, Risch, H A, Eyfjord, J E, Hopper, J L, Southey, M C, Olsson, H, Johannsson, O, Borg, A, Passini, B, Radice, P, Manoukian, S, Eccles, D M, Tang, N, Olah, E, Anton-Culver, H, Warner, E, Lubinski, J, Gronwald, J, Gorski, B, Tryggvadottir, L, Syrjakoski, K, Kallioniemi, O-P, Eerola, H, Nevanlinna, H, Pharoah, P D P, Easton, D F
Publicado 2008

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

por Antoniou, A C, Cunningham, A P, Peto, J, Evans, D G, Lalloo, F, Narod, S A, Risch, H A, Eyfjord, J E, Hopper, J L, Southey, M C, Olsson, H, Johannsson, O, Borg, A, Pasini, B, Radice, P, Manoukian, S, Eccles, D M, Tang, N, Olah, E, Anton-Culver, H, Warner, E, Lubinski, J, Gronwald, J, Gorski, B, Tryggvadottir, L, Syrjakoski, K, Kallioniemi, O-P, Eerola, H, Nevanlinna, H, Pharoah, P D P, Easton, D F
Publicado 2008